The EVAR Center

Filter Your Results




PIVOTAL Trial Update

Daniel G. Clair, MD, and Kenneth Ouriel, MD

November 2007—With enrollment more than half complete, the PIVOTAL trial aims to answer the question of the best treatment model for patients with small aneurysms.

Standardized Objective Performance Criteria and Control Datasets


April 2006—How the FDA is working to determine the potential role for these criteria in peripheral device regulation, and how they are best established.

The Costs of VAM Complications

David E. Allie, MD; Ron Smalling, MD; Chris J. Hebert, RT, RCIS; and Craig M. Walker, MD

May 2006—A surgeon's perspective on the Achilles' heel of our endovascular therapies.

CODA Balloon Catheter

Martin R. Back, MD

May 2006—Use of this device as an adjunct to successful aortic endografting for disadvantaged anatomy.

CT Versus Color Duplex Ultrasound for Surveillance After EVAR

Ali F. AbuRahma, MD

May 2006—An analysis of the correlation between the two modalities.

Design of Optimal Endoprostheses Using Mathematical Modeling

Suncica Canic, PhD; Zvonimir Krajcer, MD; and Serguei Lapin, PhD

May 2006—Are the mechanical properties of current-generation endografts suboptimal for AAA repair?

EVAR in Community Hospitals

E. Bruce McIff, MD; Robert P. Smilanich, MD; and Daniel McIff

May 2006—A community hospital approach to establishing a successful EVAR program.

A New Concept in EVAR

Dieter Raithel, MD, PhD; Lefeng Qu, MD, PhD; and Gudrun Hetzel, MD, PhD

May 2006—Anatomical fixation with the Powerlink stent graft.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.